PO.PS01.06 · 人群科学
超加工食品与黑人女性乳腺肿瘤组织中PI3K/AKT/MTOR信号通路蛋白表达之间的关联
Association between ultra-processed foods and PI3K/AKT/MTOR signaling pathway protein expression in breast tumor tissue of Black women
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:超加工食品(UPF)的摄入与乳腺癌风险升高和结局较差相关,可能通过代谢/胰岛素抵抗通路发挥作用。PI3K/AKT/MTOR信号通路在乳腺肿瘤中常发生失调。然而,关于UPF摄入如何影响乳腺组织中该通路的了解甚少,尤其是在乳腺癌死亡率最高的黑人女性中。研究这些关联可能有助于阐明乳腺癌差异背后与饮食相关的分子机制。
方法:我们研究了439例自我认定为黑人/非裔美国人、并参与了知名的人群研究“女性健康圈研究”(Women's Circle of Health Study)的乳腺癌病例的肿瘤FFPE样本。通过免疫组织化学(IHC)分析并进行数字化评分(H-score 1%—300%),检测肿瘤中MTOR、磷酸化(p)-MTOR、p-AKT和p-P70S6K的表达。在家庭访谈中通过经过验证的食物频率问卷评估乳腺癌诊断前12个月内摄入的食物和饮料。UPF根据其加工程度按NOVA分类系统进行分类。多变量逻辑回归模型估计UPF摄入(每增加1个标准差)与蛋白表达(阳性[H-score>0] vs. 阴性[H-score=0])之间关联的比值比(OR)及95%置信区间(CI),校正乳腺癌诊断年龄、社会经济状态、总能量摄入及诊断时的体质指数。
结果:我们的参与者在乳腺癌诊断前平均每天摄入5.5份UPF。超过90%的肿瘤表达MTOR和p-MTOR标志物,而p-AKT和p-P70S6K分别在38%和42%的病例中检出。较高的UPF摄入与核p-AKT阳性肿瘤(OR = 1.23;95% CI:1.00—1.51)及胞质p-P70S6K阳性肿瘤(OR = 1.20;95% CI:1.00—1.47)的几率升高显著相关。在将分析限于雌激素受体(ER)阳性肿瘤女性或无2型糖尿病者后,关联依然稳健。然而,观察到MTOR表达存在ER状态的异质性:在ER阴性亚型中,较高的UPF摄入与胞质MTOR阳性肿瘤几率升高三倍显著相关(OR = 3.27;95% CI:1.19—16.46),但在ER阳性癌症者中则无此关联(OR = 0.91;95% CI:0.68—1.22;交互作用P=0.02)。
结论:我们的发现提示,较高的UPF摄入与乳腺肿瘤组织中下游PI3K/AKT/MTOR通路的激活相关,突显了将UPF与乳腺癌发生联系起来的一种潜在生物学机制。更深入地理解UPF摄入如何影响肿瘤信号传导,可能有助于为黑人女性制定量身定制的饮食建议和干预措施。
查看英文原文 English abstract
Background: Ultra-processed food (UPF) consumption has been linked to increased breast cancer risk and poorer outcomes, potentially through metabolic/insulin resistance pathways. The PI3K/AKT/MTOR signaling pathways are frequently dysregulated in breast tumors. However, little is known about how UPF intake influences this pathway in breast tissue, particularly among Black women, who experience highest breast cancer mortality. Examining these associations may clarify diet-related molecular mechanisms underlying breast cancer disparities.
Methods: We investigated tumor FFPE samples from 439 breast cancer cases who self-identified as Black/African American and participated in the well-established population-based study, the Women's Circle of Health Study. Tumor expressions for MTOR, phosphorylated (p)-MTOR, p-AKT, and p-P70S6K were analyzed by immunohistochemistry (IHC) and digitally scored (H-score 1%-300%). Foods and drinks consumed over 12 months before breast cancer diagnosis were assessed during home interviews by validated food-frequency questionnaires. UPFs were classified according to their degree of processing using the NOVA classification system. Multivariable logistic regression models estimated odds ratios (ORs) and 95% confidence intervals (CIs) for associations between UPF intake (per 1-SD increase) and protein expression (positive [H-score>0] vs. negative [H-score=0]), adjusting for age of breast cancer diagnosis, socioeconomic status, total energy intake, and body mass index at diagnosis.
Results: Our participants consumed an average of 5.5 UPF servings/day before breast cancer diagnosis. More than 90% of tumors expressed MTOR and p-MTOR markers, whereas p-AKT and p-P70S6K were detected in 38% and 42% of cases, respectively. Higher UPF consumption was significantly associated with increased odds of nuclear p-AKT-positive tumors (OR = 1.23; 95% CI: 1.00-1.51) and cytoplasmic p-P70S6K-positive tumors (OR = 1.20; 95% CI: 1.00-1.47). Associations remained robust after restricting analyses to women with estrogen receptor (ER)-positive tumors or those without type 2 diabetes. However, heterogeneity by ER status was observed for MTOR expression: higher UPF intake was significantly associated with a threefold greater odds of cytoplasmic MTOR-positive tumors among ER-negative subtype (OR = 3.27; 95% CI: 1.19-16.46) but not among those with ER-positive cancer (OR = 0.91; 95% CI: 0.68-1.22; P-interaction=0.02).
Conclusion: Our findings suggest that higher UPF intake was associated with activation of downstream PI3K/AKT/MTOR pathway in breast tumor tissue, highlighting a potential biological mechanism linking UPFs to breast cancer development. A deeper understanding of how UPF consumption influences tumor signaling may inform the development of tailored dietary recommendations and interventions for Black women.
利益披露 Disclosure
T. Wang, None..
B. Qin, None..
F. K. Tabung, None..
S. Zheng, None..
N. Zeinomar, None..
C. Hong, None..
C. B. Ambrosone, None..
E. V. Bandera, None..
T. D. Cheng, None.